Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary function assessment during bleomycin therapy.

E Lampert-Benignus, F Eichler-Reiss, J Meunier-Carius

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients.

    Cancer chemotherapy and pharmacology·2000
    Same author

    [Survival results after 10 years of 39 patients with inflammatory breast cancer treated by two different neoadjuvant chemotherapy protocols].

    Bulletin du cancer·1996
    Same author

    Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1993
    Same author

    Phase II trials of tetrahydropyranyl-adriamycin (Pirarubicin) on renal and colon carcinoma, melanoma, and soft tissue sarcoma.

    American journal of clinical oncology·1993
    Same author

    Carcinoma of the cervical stump: a review of 213 cases.

    European journal of cancer (Oxford, England : 1990)·1993
    Same author

    Cervical and vaginal cancer associated with pessary use.

    Cancer·1992
    Same journal

    Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    Same journal

    Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
    See all related articles

    This study found no significant pulmonary toxicity in male patients treated with chemotherapy, including Bleomycin. Lung function tests remained stable, suggesting Bleomycin

    Area of Science:

    • Oncology
    • Pulmonology
    • Pharmacology

    Background:

    • Chemotherapy regimens often include agents with potential pulmonary toxicity.
    • Bleomycin is known to cause lung damage, necessitating careful monitoring.
    • Assessing early markers of Bleomycin-induced lung injury is crucial for patient management.

    Purpose of the Study:

    • To evaluate the utility of spirometry and diffusing capacity tests in detecting early pulmonary toxicity from Bleomycin.
    • To assess changes in lung function parameters following combination chemotherapy including Bleomycin.

    Main Methods:

    • 20 male patients with various tumors received combination chemotherapy, primarily with Cis-diammino-dichloroplatinum, Methotrexate, and Bleomycin.
    • Pulmonary function tests, including spirometry, carbon monoxide diffusing capacity (DLCO), membrane diffusing capacity (Dm), and capillary blood volume (Vc), were performed.

    Related Experiment Videos

  • Tests were conducted before each chemotherapy course and at the study's end.

    • Main Results:

    • No statistically significant changes were observed in ventilatory or diffusional tests across the 20 patients.
    • A minor decrease in DLCO was noted in 3 patients who received the highest dose of Bleomycin (300 mg).

    Conclusions:

    • Standard pulmonary function tests did not reveal significant Bleomycin-induced lung toxicity in this cohort.
    • Factors such as patient selection (no cardiopulmonary history), mean Bleomycin dose below the toxic threshold, and study duration may explain the lack of significant findings.